Growth Metrics

Pacira BioSciences (PCRX) Amortizatization of Intangibles (2016 - 2026)

Pacira BioSciences has reported Amortizatization of Intangibles over the past 17 years, most recently at $570000.0 for Q1 2026.

  • For Q1 2026, Amortizatization of Intangibles fell 70.16% year-over-year to $570000.0; the TTM value through Mar 2026 reached $5.5 million, down 41.17%, while the annual FY2025 figure was $4.9 million, 33.61% down from the prior year.
  • Amortizatization of Intangibles for Q1 2026 was $570000.0 at Pacira BioSciences, down from $4.8 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $7.4 million in Q4 2024 and troughed at $23000.0 in Q2 2024.
  • A 5-year average of $1.3 million and a median of $675000.0 in 2023 define the central range for Amortizatization of Intangibles.
  • Biggest five-year swings in Amortizatization of Intangibles: tumbled 96.44% in 2024 and later skyrocketed 7858.33% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $700000.0 in 2022, then skyrocketed by 449.71% to $3.8 million in 2023, then skyrocketed by 91.03% to $7.4 million in 2024, then tumbled by 34.35% to $4.8 million in 2025, then plummeted by 88.19% to $570000.0 in 2026.
  • Business Quant data shows Amortizatization of Intangibles for PCRX at $570000.0 in Q1 2026, $4.8 million in Q4 2025, and $56000.0 in Q3 2025.